Key result
Endovascular aneurysm repair (EVAR) has evolved through advances in device technology to rival open surgical repair as the standard treatment for aortoiliac aneurysm disease.
This review outlines the historical progress, technological advances, complications, and nursing implications of endovascular aneurysm repair for abdominal aortic aneurysms.
Supports evolution toward EVAR for AAA; leaves open optimal perioperative protocols in modern practice.
Effective treatment for patients with an abdominal aortic aneurysm (AAA) began more than 50 years ago through the development of prosthetic grafts, which were used to replace aneurysmal segments of diseased arteries. Open surgical repair of AAAs became the gold standard for treating this disease. In 1999, two device manufacturers received US Food and Drug Administration approval for their endovascular aneurysm repair (EVAR) devices to treat selected patients with AAA. During the next 10 years, multiple other EVAR devices received US Food and Drug Administration approval, and, now, EVAR rivals open surgical repair as the standard for treating aortoiliac aneurysm disease. The purpose of this article is to outline advances in the device technology used for EVAR procedures, identify historical progress of treatment options, recognize complications after EVAR, describe improvements in device design, and specify related nursing implications.
No takes yet. Share an insight, caveat, or question.
Buckley et al. (2014) conducted a review in Abdominal aortic aneurysm (AAA). Endovascular aneurysm repair (EVAR) vs. Open surgical repair was evaluated. Endovascular aneurysm repair (EVAR) has evolved through advances in device technology to rival open surgical repair as the standard treatment for aortoiliac aneurysm disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: